Namale, Phiona E. http://orcid.org/0000-0003-4024-0626
Boloko, Linda
Vermeulen, Marcia
Haigh, Kate A.
Bagula, Fortuna
Maseko, Alexis
Sossen, Bianca
Lee-Jones, Scott
Msomi, Yoliswa
McIlleron, Helen
Mnguni, Ayanda Trevor
Crede, Thomas
Szymanski, Patryk
Naude, Jonathan
Ebrahim, Sakeena
Vallie, Yakoob
Moosa, Muhammed Shiraz
Bandeker, Ismail
Hoosain, Shakeel
Nicol, Mark P.
Samodien, Nazlee
Centner, Chad
Dowling, Wentzel
Denti, Paolo
Gumedze, Freedom
Little, Francesca
Parker, Arifa
Price, Brendon
Schietekat, Denzil
Simmons, Bryony
Hill, Andrew
Wilkinson, Robert J.
Oliphant, Ida
Hlungulu, Siphokazi
Apolisi, Ivy
Toleni, Monica
Asare, Zimkhitha
Mpalali, Mkanyiseli Kenneth
Boshoff, Erica
Prinsloo, Denise
Lakay, Francisco
Bekiswa, Abulele
Jackson, Amanda
Barnes, Ashleigh
Johnson, Ryan
Wasserman, Sean
Maartens, Gary
Barr, David
Schutz, Charlotte
Meintjes, Graeme
Funding for this research was provided by:
Wellcome Trust - (214321/Z/18/Z Recipient Prof Graeme Meintjes)
Article History
Received: 16 January 2024
Accepted: 16 April 2024
First Online: 8 May 2024
Declarations
:
: Ethical approval for the trial was obtained from the University of Cape Town Faculty of Health Sciences Human Research Ethical Committee, before the trial was initiated (Ref: 001/2021). The trial adheres to ICH Good Clinical Practice guidelines, South African GCP guidelines of 2019 and the Declaration of Helsinki of hs018. Regulatory approval for the trial was obtained from the South African Health Products Authority (Tracking number: 20210328).This trial is registered with Clinical Trials.gov NCT04951986 and the South African National Clinical Trials Register (SANCTR) DOH-27072021-4806.
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.
: There are no competing interests to declare.